Skip to content

Clinical trials

Phase 3 Severe Acute Respiratory Syndrome trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Phase: Phase 3 Country / region: Brazil Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20205
20215
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Withdrawn3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Applied Biology, Inc.3
Cardresearch2
Apsen Farmaceutica S.A.1
AstraZeneca1
Population Health Research Institute1
Rigel Pharmaceuticals1
University of Sao Paulo General Hospital1
Veru Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome11
COVID-198
Coronavirus Infections5
Lung Diseases2
Virus Diseases2
Hemostatic Disorders1
Infections1
Influenza, Human1
Pneumonia1
Pneumonia, Viral1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.